Viatris will look to tap the novel brands expertise of Philippe Martin after appointing the former Celgene and Schering-Plough exec as the company’s chief R&D officer with immediate effect, marking yet another step in its recent structural efforts to pivot from off-patent products and move up the value chain to innovative products.
“As chief R&D officer, Martin brings with him significant innovative product development experience across R&D, scientific and regulatory affairs,” Viatris noted, including at Celgene, where he led the development and global
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?